Distinguishing Patients With Distant Metastatic Differentiated Thyroid Cancer Who Biochemically Benefit From Next Radioiodine Treatment

BACKGROUND: Repeated radioiodine ((131)I) treatment (RT) are commonly performed in patients with (131)I-avid distant metastatic differentiated thyroid cancer (DM-DTC), but more precise indications remain indeterminate. This prospective study was conducted to explore predictors for biochemical respon...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Endocrinol (Lausanne)
Egile Nagusiak: Sa, Ri, Cheng, Lin, Jin, Yuchen, Fu, Hao, Shen, Yan, Chen, Libo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2020
Gaiak:
Endocrinology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7701118/
https://ncbi.nlm.nih.gov/pubmed/33304320
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2020.587315
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak